These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 12436221

  • 21. Chemotherapy-induced nausea and vomiting: clinician and patient perspectives.
    Schwartzberg LS.
    J Support Oncol; 2007 Feb; 5(2 Suppl 1):5-12. PubMed ID: 17366928
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Acute and delayed nausea and emesis control in pediatric oncology patients.
    Holdsworth MT, Raisch DW, Frost J.
    Cancer; 2006 Feb 15; 106(4):931-40. PubMed ID: 16404740
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Measuring the maintenance of daily life activities using the functional living index-emesis (FLIE) in patients receiving moderately emetogenic chemotherapy.
    Decker GM, DeMeyer ES, Kisko DL.
    J Support Oncol; 2006 Jan 15; 4(1):35-41, 52. PubMed ID: 16444851
    [Abstract] [Full Text] [Related]

  • 28. Using preference-based measures to assess quality of life in stuttering.
    Bramlett RE, Bothe AK, Franic DM.
    J Speech Lang Hear Res; 2006 Apr 15; 49(2):381-94. PubMed ID: 16671851
    [Abstract] [Full Text] [Related]

  • 29. Quality of life consequences of chemotherapy-induced emesis.
    Lindley CM, Hirsch JD, O'Neill CV, Transau MC, Gilbert CS, Osterhaus JT.
    Qual Life Res; 1992 Oct 15; 1(5):331-40. PubMed ID: 1299465
    [Abstract] [Full Text] [Related]

  • 30. The oral NK(1) antagonist, aprepitant, given with standard antiemetics provides protection against nausea and vomiting over multiple cycles of cisplatin-based chemotherapy: a combined analysis of two randomised, placebo-controlled phase III clinical trials.
    de Wit R, Herrstedt J, Rapoport B, Carides AD, Guoguang-Ma J, Elmer M, Schmidt C, Evans JK, Horgan KJ.
    Eur J Cancer; 2004 Feb 15; 40(3):403-10. PubMed ID: 14746859
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Long-term adjustment of survivors of early-stage breast carcinoma, 20 years after adjuvant chemotherapy.
    Kornblith AB, Herndon JE, Weiss RB, Zhang C, Zuckerman EL, Rosenberg S, Mertz M, Payne D, Jane Massie M, Holland JF, Wingate P, Norton L, Holland JC.
    Cancer; 2003 Aug 15; 98(4):679-89. PubMed ID: 12910510
    [Abstract] [Full Text] [Related]

  • 36. A patient report measure for the quantification of chemotherapy induced nausea and emesis: psychometric properties of the Morrow assessment of nausea and emesis (MANE).
    Morrow GR.
    Br J Cancer Suppl; 1992 Dec 15; 19():S72-4. PubMed ID: 1467207
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Chemotherapy-induced nausea and vomiting: state of the art in 2006.
    Schwartzberg L.
    J Support Oncol; 2006 Feb 15; 4(2 Suppl 1):3-8. PubMed ID: 16499138
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Behavioral interventions and psychological aspects of care during chemotherapy].
    Fallowfield LJ.
    Soins; 1993 Apr 15; (571):40-2. PubMed ID: 8303399
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.